28 June 2022 It is with great pleasure that EASL announces that their first open-access journal JHEP Reports has received its first impact factor ever of 9.917. This milestone event has taken place only three years after the publication of its…
The European Association for the Study of the Liver (EASL) has improved the way you will connect to all our EASL applications with a new Single Sign On solution. One username, one password for all our applications. You will soon…
EASL is pleased to introduce the 2022 EASL Social Media Ambassadors! Discover the line-up here below and follow them.
Follow us @easl.news on Instagram Like the contest post Comment under the post what you like most about EASL and our Instagram account Tag a friend For an EXTRA chance of winning, choose + repost your favourite picture from our…
1 June 2022 EASL is proud to announce the release of EASL Clinical Practice Guidelines on Haemochromatosis, just published in the Journal of Hepatology. This marks World Haemochromatosis Week taking place every year in the first week of June.
27 May 2022 This European Week Against Cancer (#EWAC22), EASL is tackling liver cancer by publishing a Policy Statement on liver cancer screening. This Policy Statement is written by EASL Policy and Public Health Committee member, Prof. Peter Jepsen, with…
For Immediate Release EASL Statement on cases of severe acute hepatitis in children of unknown causes EASL to host live panel discussion Tuesday May 24 at 18:00 CEST Thursday May 19, 2022 (Geneva, Switzerland) -- The European Association for the…
12 April 2022 EASL has recently published its first ever accessible lay summary on how to tackle non-alcoholic fatty liver disease (NAFLD). This 20-page summary is intended for the general public, people at risk of – or already living with…
25 March 2022 On 15 March 2022, the Members of Parliament (MEP) Friends of the Liver Group (hereafter “the Group”), coordinated by EASL was relaunched online. To mark the occasion, a webinar was held to discuss the increasing burden of…
